Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Ph+ Acute Lymphoblastic Leukemia (ALL).
Adult patients with chronic lymphocytic leukemia (CLL) / small lymphocytic lymphoma (SLL), Waldenström's macroglobulinemia, and chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.